Correlation Between Abattis Bioceuticals and Aion Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abattis Bioceuticals and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abattis Bioceuticals and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abattis Bioceuticals Corp and Aion Therapeutic, you can compare the effects of market volatilities on Abattis Bioceuticals and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abattis Bioceuticals with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abattis Bioceuticals and Aion Therapeutic.

Diversification Opportunities for Abattis Bioceuticals and Aion Therapeutic

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Abattis and Aion is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abattis Bioceuticals Corp and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and Abattis Bioceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abattis Bioceuticals Corp are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of Abattis Bioceuticals i.e., Abattis Bioceuticals and Aion Therapeutic go up and down completely randomly.

Pair Corralation between Abattis Bioceuticals and Aion Therapeutic

If you would invest  1.10  in Aion Therapeutic on September 1, 2024 and sell it today you would lose (0.05) from holding Aion Therapeutic or give up 4.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.21%
ValuesDaily Returns

Abattis Bioceuticals Corp  vs.  Aion Therapeutic

 Performance 
       Timeline  
Abattis Bioceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Abattis Bioceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Abattis Bioceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Aion Therapeutic 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aion Therapeutic are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, Aion Therapeutic reported solid returns over the last few months and may actually be approaching a breakup point.

Abattis Bioceuticals and Aion Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abattis Bioceuticals and Aion Therapeutic

The main advantage of trading using opposite Abattis Bioceuticals and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abattis Bioceuticals position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.
The idea behind Abattis Bioceuticals Corp and Aion Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Transaction History
View history of all your transactions and understand their impact on performance